Spanish Working Grp MDR-TB, Spanish Working Grp MDR-TB. Long-term molecular surveillance of multidrug-resistant tuberculosis in Spain.

Gavin P, Iglesias M, Jiménez MS, Rodríguez-Valin E, Ibarz D, Lezcano MA, Revillo MJ, Martín C, Samper S.

Infect. Genet. Evol. 2012; 12: 701-710. FI: 3.128 (Q2).

Grp Espahol Para Estudio VIH-HTLV. Infection by HIV-2, HTLV and new human retroviruses in Spain.

Treviño A, Soriano V.

Med. Clin. 2012; 138: 541-544. FI: 1.385 (Q2).

Molecular characterization of Staphylococcus aureus carrying the panton-valentine leucocidin genes in northern Spain.

Marimón JM, Villar M, García-Arenzana JM, De la Caba I, Pérez-Trallero E.

J. Infect. 2012; 64: 47-53. FI: 4.126 (Q1).

CIBERESP Cases Controls Pandemic. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: influence of neuraminidase inhibitors.

Delgado-Rodríguez M, Castilla J, Godoy P, Martín V, Soldevila N, Alonso J, Astray J, Baricot M, Cantón R, Castro A, González-Candelas F, Mayoral JM, Quintana JM, Pumarola T, Tamames S, Sáez M, Domínguez A.

J. Antimicrob. Chemother. 2012; 67: 1739-1745. FI: 5.068 (Q1).

GETGAG. Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically III Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/H1N1 in seriously ill adults admitted to the Intensive Care Unit.

Rodríguez A, Álvarez-Rocha L, Sirvent JM, Zaragoza R, Nieto M, Arenzana A, Luque P, Socias L, Martin M, Navarro D, Camarena J, Lorente L, Trefler S, Vidaur L, Sole-Violan J, Barcenilla F, Pobo A, Valles J, Ferri C, Martin-Loeches I, Diaz E, López D, López-Pueyo MJ, Gordo F, Del Nogal F, Marques A, Tormo S, Fuset MP, Pérez F, Bonastre J, Suberviola B, Navas E, Leon C.

Med. Intensiv. 2012; 36: 103-137. FI: 1.072 (Q4).

MARBEGRIP Res Grp. Seroprevalence of antibodies to the influenza A (H1N1) virus among healthcare workers prior to the 2009 pandemic peak.

Olalla J, De Ory F, Casas I, Del Arco A, Montiel N, Rivas-Ruiz F, De la Torre J, Prada JL, Fernández F, García-Alegría J.

Enferm. Infec. Microbiol. Clin. 2012; 30: 371-375. FI: 1.491 (Q3).

ESICM HINI Registry Steering Comm, ESICM HINI Registry Contributors. Severity assessment tools in ICU patients with 2009 Influenza A (H1N1) pneumonia.

Pereira JM, Moreno RP, Matos R, Rhodes A, Martín-Loeches I, Cecconi M, Lisboa T, Rello J.

Clin. Microbiol. Infect. 2012; 18: 1040-1048. FI: 4.540 (Q1).

CIBERESP Cases Controls Pandemic. Sociodemographic Factors and Clinical Conditions Associated to Hospitalization in Influenza A (H1N1) 2009 Virus Infected Patients in Spain, 2009-2010.

González-Candelas F, Astray J, Alonso J, Castro A, Cantón R, Galán JC, Garin O, Sáez M, Soldevila N, Baricot M, Castilla J, Godoy P, Delgado-Rodríguez M, Martín V, Mayoral MJ, Pumarola T, Quintana MJ, Tamames S, Domínguez, A.

PLoS One. 2012; 7: -0. FI: 4.092 (Q1).

ISAAC Phase Three Study Grp. The association between tobacco and the risk of asthma, rhinoconjunctivitis and eczema in children and adolescents: analyses from Phase Three of the ISAAC programme.

Mitchell EA, Beasley R, Kei, U, Montefort S, Odhiambo J.

Thorax. 2012; 67: 941-128. FI: 6.840 (Q1).

Spanish Clostridium Difficile Stud. The undiagnosed cases of Clostridium difficile infection in a whole nation: where is the problem?

Alcala L, Martín A, Marín M, Sánchez-Somolinos M, Catalán P, Peláez T, Bouza E.

Clin. Microbiol. Infect. 2012; 18: 204-213. FI: 4.540 (Q1).

HTLV Spanish Study Grp. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain.

Treviño A, Aguilera A, Caballero E, Benito R, Parra P, Eiros JM, Hernández A, Calderón E, Rodríguez M, Torres A, García JM, Ramos J, Roc L, Marcaida G, Rodríguez C, Trigo M, Gómez C, Ortíz de Lejarazu R, De Mendoza C, Soriano V

Virol. J. 2012; 9: -0. FI: 2.343 (Q3).